VanEck Associates
DOCS icon

VanEck Associates’s Doximity DOCS Stock Holding History

VanEck Associates’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-103,984
Closed -$2.42M – 1368
2026
Q1 		$2.42M Buy
103,984
+3,386
+3% +$106K ﹤0.01% 954
2025
Q4 		$4.45M Buy
100,598
+11,792
+13% +$662K ﹤0.01% 822
2025
Q3 		$6.5M Buy
88,806
+2,014
+2% +$131K 0.01% 669
2025
Q2 		$5.32M Buy
86,792
+84,471
+3,639% +$4.71M 0.01% 706
2025
Q1 		$135K Sell
2,321
-31
-1% -$1.96K ﹤0.01% 1258
2024
Q4 		$126K Buy
2,352
+388
+20% +$19K ﹤0.01% 1263
2024
Q3 		$81K Sell
1,964
-626
-24% -$20.9K ﹤0.01% 1260
2024
Q2 		$72K Buy
2,590
+427
+20% +$11.3K ﹤0.01% 1270
2024
Q1 		$58K Buy
2,163
+287
+15% +$8.18K ﹤0.01% 1272
2023
Q4 		$53K Sell
1,876
-33
-2% -$779 ﹤0.01% 1283
2023
Q3 		$41K Sell
1,909
-62
-3% -$1.69K ﹤0.01% 1297
2023
Q2 		$67K Buy
+1,971
New +$65.6K ﹤0.01% 1283

Other funds holding DOCS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

VanEck Associates's DOCS Position: Q2 2026 in Review

VanEck Associates sold out of Doximity (DOCS) in Q2 2026, closing a stake of 103,984 shares — an estimated $2.42M sold.

VanEck Associates first reported a position in DOCS in Q2 2023 and held it in 12 quarters. The position peaked at $6.5M in Q3 2025. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • VanEck Associates reported no remaining Doximity position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 103,984 Doximity shares in Q2 2026, an estimated $2.42M.
  • VanEck Associates first reported a position in Doximity in Q2 2023 and held it in 12 quarters.
  • VanEck Associates's Doximity position peaked at $6.5M in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.